We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Medical Information Website: http://www.pfizermedicalinformation.ie
Patient Information Leaflet last updated on medicines.ie: 16/06/2017
PIL Inlyta 1 mg 3mg, 5 mg & 7mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/06/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Removal of black triangle
Updated on 26/06/2015 and displayed until 16/06/2017
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 18/06/2015 and displayed until 26/06/2015
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/06/2014 and displayed until 18/06/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 29/11/2013 and displayed until 24/06/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
Updated on 30/08/2013 and displayed until 29/11/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Change to improve clarity and readability
  • Introduction of new pack/pack size
  • Improved electronic presentation
  • Introduction of new strength
Updated on 01/03/2013 and displayed until 30/08/2013
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Axitinib